Alerts will be sent to your verified email
Verify Email
FREDUN
|
Fredun Pharma
|
Trident Lifeline
|
Gennex Lab
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
8.53 % | 35.94 % | 7.82 % |
|
5yr average Equity Multiplier
|
3.02 | 1.91 | 1.53 |
|
5yr Average Asset Turnover Ratio
|
1.01 | 0.9 | 0.75 |
|
5yr Avg Net Profit Margin
|
2.89 % | 17.11 % | 7.88 % |
|
Price to Book
|
2.43 | 5.73 | 1.61 |
|
P/E
|
16.54 | 28.09 | 18.65 |
|
5yr Avg Cash Conversion Cycle
|
137.13 Days | 94.4 Days | 43.23 Days |
|
Inventory Days
|
140.46 Days | 68.55 Days | 49.12 Days |
|
Days Receivable
|
52.11 Days | 104.41 Days | 50.53 Days |
|
Days Payable
|
131.93 Days | 126.58 Days | 75.36 Days |
|
5yr Average Interest Coverage Ratio
|
2.31 | 17.94 | 6.21 |
|
5yr Avg ROCE
|
16.75 % | 29.15 % | 11.17 % |
|
5yr Avg Operating Profit Margin
|
8.32 % | 16.89 % | 10.47 % |
|
5 yr average Debt to Equity
|
0.86 | 0.34 | 0.18 |
|
5yr CAGR Net Profit
|
52.4 % | 9.93 % | 43.63 % |
|
5yr Average Return on Assets
|
3.05 % | 15.87 % | 5.16 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
48.93 % | 63.04 % | 18.42 % |
|
Share Pledged by Promoters
|
0.0 | 3.46 % | 23.87 % |
|
Change in Promoter Holding (3 Yrs)
|
-2.34 % | -6.53 % | -3.63 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |